SHPMF Statistics
Total Valuation
Shanghai Pharmaceuticals Holding has a market cap or net worth of 8.90 billion. The enterprise value is 12.48 billion.
| Market Cap | 8.90B |
| Enterprise Value | 12.48B |
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | Sep 17, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.83% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.82B |
Valuation Ratios
The trailing PE ratio is 15.50.
| PE Ratio | 15.50 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 1.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.84, with an EV/FCF ratio of 27.43.
| EV / Earnings | 21.75 |
| EV / Sales | 0.33 |
| EV / EBITDA | 8.84 |
| EV / EBIT | 10.83 |
| EV / FCF | 27.43 |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.34 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 5.46 |
| Debt / FCF | 17.63 |
| Interest Coverage | 4.65 |
Financial Efficiency
Return on equity (ROE) is 6.41% and return on invested capital (ROIC) is 3.86%.
| Return on Equity (ROE) | 6.41% |
| Return on Assets (ROA) | 2.41% |
| Return on Capital (ROIC) | 3.86% |
| Revenue Per Employee | 806,330 |
| Profits Per Employee | 11,915 |
| Employee Count | 48,164 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 6.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.72% in the last 52 weeks. The beta is 0.32, so Shanghai Pharmaceuticals Holding's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +5.72% |
| 50-Day Moving Average | 1.46 |
| 200-Day Moving Average | 1.61 |
| Relative Strength Index (RSI) | 51.14 |
| Average Volume (20 Days) | 10,739 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shanghai Pharmaceuticals Holding had revenue of 38.84 billion and earned 573.87 million in profits. Earnings per share was 0.15.
| Revenue | 38.84B |
| Gross Profit | 4.30B |
| Operating Income | 1.20B |
| Pretax Income | 1.02B |
| Net Income | 573.87M |
| EBITDA | 1.37B |
| EBIT | 1.20B |
| Earnings Per Share (EPS) | 0.15 |
Balance Sheet
The company has 6.04 billion in cash and 8.02 billion in debt, giving a net cash position of -1.98 billion.
| Cash & Cash Equivalents | 6.04B |
| Total Debt | 8.02B |
| Net Cash | -1.98B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 11.86B |
| Book Value Per Share | 2.73 |
| Working Capital | 6.31B |
Cash Flow
In the last 12 months, operating cash flow was 814.32 million and capital expenditures -359.44 million, giving a free cash flow of 454.88 million.
| Operating Cash Flow | 814.32M |
| Capital Expenditures | -359.44M |
| Free Cash Flow | 454.88M |
| FCF Per Share | n/a |
Margins
Gross margin is 11.07%, with operating and profit margins of 3.09% and 1.48%.
| Gross Margin | 11.07% |
| Operating Margin | 3.09% |
| Pretax Margin | 2.64% |
| Profit Margin | 1.48% |
| EBITDA Margin | 3.53% |
| EBIT Margin | 3.09% |
| FCF Margin | 1.17% |
Dividends & Yields
This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 4.31%.
| Dividend Per Share | 0.07 |
| Dividend Yield | 4.31% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 85.84% |
| Buyback Yield | 0.83% |
| Shareholder Yield | 5.14% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Shanghai Pharmaceuticals Holding has an Altman Z-Score of 2.08. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.08 |
| Piotroski F-Score | n/a |